The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Sudhir Sethi, the main promoter of Beryl Drugs Ltd, has acquired 7,500 equity shares (0.14% of the company's total share capital) through open-market transactions on 23 March 2026. This was disclosed to the BSE under Regulation 29(2) of SEBI's Takeover Regulations. As a result, his holding has increased from 4,78,983 shares (9.44%) to 4,86,483 shares (9.58%) of the company. The total equity share capital of the company remains 50,71,700 shares. This is a small, incremental open-market purchase by the promoter, not a large block deal.
This is a minor promoter buy, suggesting continued promoter confidence in the company. The acquisition is too small (0.14%) to materially affect the stock price, but it indicates the promoter is gradually increasing their stake in the open market.